High blood pressure and glucose intolerance are among the most dangerous cardiometabolic risk factors for adults with metabolic dysfunction-associated steatotic liver disease, study results ...

Heterogeneity in protocols across centers has contributed to a lack of long-term outcomes for different active surveillance protocols.

A Q&A with Sophia Humphreys, PharmD, MHA, BCBBS; Robert Gluckman, MD, MACP; and Elie M. Bahou, PharmD, MBA. Please visit "Biosimilars Integration Insights: a Stakeholder Case Study" to read the full ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced the appointment of James B. Jones, MD, PharmD, to the position of senior vice president and chief medical ...

Please provide your email address to receive an email when new articles are posted on . Why ID? Cue the iconic theme music from the medical drama House. My medical journey started in 2004 as a ...

PLAYA DEL REY, Calif., Dec. 19, 2018 /PRNewswire/ -- Edward G. Stokes, MD, Pharm. D. is recognized by Continental Who's Who as a Pinnacle Lifetime Member in the field of Medicine in recognition of his ...

WILMINGTON, Del.--(BUSINESS WIRE)--Dermaliq Therapeutics, Inc. (Dermaliq), a private biopharmaceutical company with therapeutic focus on dermatology, today announces the formation of a Scientific and ...

Current research indicates that short-term utilization of an LFD may help ameliorate some mild IBS symptoms associated with quiescent IBD, while further long term studies are still needed.